Sanofi reduces US insulin prices for the uninsured
While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.
by christopher due karlsson, translated by catherine brett
On Friday, French pharmaceutical firm Sanofi reduced its insulin price for uninsured patients in the US significantly. This comes as the Affordable Insulin Now Act has passed the House of Representatives, and a bi-partisan bill to cap costs is being introduced to the Senate.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
US Senators introduce bill to cap insulin prices
For subscribers
.jpg)
.jpg&w=384&q=75)
